Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (96740)	11/26/2001 12:07:47 PM
From: jmhollen	Respond to of 150070

Nasdaq Halts Trading of American Biogenetic Sci ( MABA ) WASHINGTON -(Dow Jones)- The Nasdaq Stock Market halted trading of American Biogenetic Sciences Inc. (MABA) this morning for "additional information requested" from the company. The company's shares last traded at 73 cents. In a press release Monday, Nasdaq said trading will remain halted until the company fully satisfies the exchange's request. Earlier this morning, American Biogenetic said it signed a 10-year agreement with the Ministry of Health of the Russian Federation that covers human vaccines for anthrax, smallpox, botulism and other diseases. (This story was originally published by Dow Jones Newswires) Copyright (c) 2001 Dow Jones & Company, Inc. All Rights Reserved ************************************* CONTACT: Wayne Lee of The Nasdaq Stock Market, +1-202-728-8067/ .